June 24, 2017 2:01 PM ET


Company Overview of Igeneon GmbH

Company Overview

Igeneon GmbH develops and supplies cancer vaccines. It offers antibodies and other components of the patient's immune system to combat cancer. The company was founded in 1999 and is based in Vienna, Austria. As of March 24, 2005, Igeneon GmbH operates as a subsidiary of Aphton Corp.

Brunner Strasse 69

Obj. 3

Vienna,  1230


Founded in 1999


43 1 902 50


43 1 902 50 901

Key Executives for Igeneon GmbH

Compensation as of Fiscal Year 2016.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Igeneon GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.